Skip to content
★ Sign in to follow
AM

Artes Medical Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Costantino John R, was filed 29 Sept 2008.

Artes Medical Inc: what insiders have been doing

Artes Medical Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Artes Medical Inc has published a filing in the past twelve months. The most recent one dates from 29 September 2008.

Over the whole record (from 2006), the tally stands at 27 purchases and no sales.

This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
36
Thresholds
n/a
Buy Volume
€2M
27 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 29 September 2008
Declarations36 total
  • ▲
    DirectorExecutives
    104,899 USD0SEC
    129,107 shares@ US$0.8125Common StockSEC:0001209191-08-053731:0
    Canonical exit: 25 Dec 2008 (T+90)
  • ▲
    DirectorExecutives
    145,100 USD0SEC
    178,584 shares@ US$0.8125Common StockSEC:0001209191-08-053731:1
    Canonical exit: 25 Dec 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    3,317 USD0SEC
    3,100 shares@ US$1.07Common StockSEC:0001209191-08-031896:0
    Canonical exit: 12 Aug 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    3,348 USD0SEC
    3,100 shares@ US$1.08Common StockSEC:0001209191-08-031896:1
    Canonical exit: 12 Aug 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    642 USD0SEC
    600 shares@ US$1.07Common StockSEC:0001209191-08-031896:2
    Canonical exit: 12 Aug 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    212 USD0SEC
    200 shares@ US$1.06Common StockSEC:0001209191-08-031896:3
    Canonical exit: 12 Aug 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    105 USD0SEC
    100 shares@ US$1.05Common StockSEC:0001209191-08-031896:4
    Canonical exit: 12 Aug 2008 (T+90)
  • ▲
    Exec Chmn Board of DirectorsExecutives
    19,157 USD0SEC
    7,175 shares@ US$2.67Common StockSEC:0001209191-07-068444:0
    Canonical exit: 6 Mar 2008 (T+90)
  • ▲
    DirectorExecutives
    36,568 USD0SEC
    14,686 shares@ US$2.49Common StockSEC:0001209191-07-066734:0
    Canonical exit: 26 Feb 2008 (T+90)
  • ▲
    DirectorExecutives
    18,064 USD0SEC
    6,294 shares@ US$2.87Common StockSEC:0001209191-07-066734:1
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    DirectorExecutives
    50,582 USD0SEC
    20,314 shares@ US$2.49Common StockSEC:0001209191-07-066734:2
    Canonical exit: 26 Feb 2008 (T+90)
  • ▲
    DirectorExecutives
    24,986 USD0SEC
    8,706 shares@ US$2.87Common StockSEC:0001209191-07-066734:3
    Canonical exit: 27 Feb 2008 (T+90)
  • ▲
    Chief Legal, Gen Counsel & SecExecutives
    456 USD0SEC
    200 shares@ US$2.28Common StockSEC:0001209191-07-066232:0
    Canonical exit: 21 Feb 2008 (T+90)
  • ▲
    Chief Legal, Gen Counsel & SecExecutives
    229 USD0SEC
    100 shares@ US$2.29Common StockSEC:0001209191-07-066232:1
    Canonical exit: 21 Feb 2008 (T+90)
  • ▲
    Chief Legal, Gen Counsel & SecExecutives
    3,927 USD0SEC
    1,700 shares@ US$2.31Common StockSEC:0001209191-07-066232:2
    Canonical exit: 21 Feb 2008 (T+90)
  • ▲
    Chief Legal, Gen Counsel & SecExecutives
    269 USD0SEC
    125 shares@ US$2.15Common StockSEC:0001209191-07-066232:3
    Canonical exit: 24 Feb 2008 (T+90)
  • ▲
    Executive VP and CFOExecutives
    219 USD0SEC
    100 shares@ US$2.19Common StockSEC:0001209191-07-066233:0
    Canonical exit: 24 Feb 2008 (T+90)
  • ▲
    Executive VP and CFOExecutives
    8,322 USD0SEC
    3,800 shares@ US$2.19Common StockSEC:0001209191-07-066233:1
    Canonical exit: 24 Feb 2008 (T+90)
  • ▲
    Executive VP and CFOExecutives
    2,420 USD0SEC
    1,100 shares@ US$2.20Common StockSEC:0001209191-07-066233:2
    Canonical exit: 24 Feb 2008 (T+90)
  • ▲
    Executive VP and CFOExecutives
    11,250 USD0SEC
    5,000 shares@ US$2.25Common StockSEC:0001209191-07-066233:3
    Canonical exit: 24 Feb 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    9,589 USD0SEC
    4,300 shares@ US$2.23Common StockSEC:0001209191-07-066079:0
    Canonical exit: 19 Feb 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    1,561 USD0SEC
    700 shares@ US$2.23Common StockSEC:0001209191-07-066079:1
    Canonical exit: 19 Feb 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    6,750 USD0SEC
    3,000 shares@ US$2.25Common StockSEC:0001209191-07-066079:2
    Canonical exit: 19 Feb 2008 (T+90)
  • ▲
    VP US Sales & TrainingExecutives
    4,500 USD0SEC
    2,000 shares@ US$2.25Common StockSEC:0001209191-07-066079:3
    Canonical exit: 19 Feb 2008 (T+90)
  • ▲
    President & CEOExecutives
    50,820 USD0SEC
    24,200 shares@ US$2.10Common StockSEC:0001209191-07-065584:0
    Canonical exit: 18 Feb 2008 (T+90)

25 of 36 declarations

About Artes Medical Inc

Artes Medical Inc is a company focused on developing innovative medical solutions. It is listed on the XNAS market.